Dako A/S (Acquired by Agilent Technologies, Inc.), An Agilent Technologies, Inc. (Santa Clara, California) Company, Launches Two Ready-To-Use Antibodies For Cancer Diagnosis

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GLOSTRUP, Denmark, May 2, 2014 (GLOBE NEWSWIRE) -- Dako, an Agilent Technologies company and worldwide provider of cancer diagnostic solutions , today announced the addition of two new antibodies, Anti-CK 8/18 and Anti-TdT, to the Dako portfolio of high-quality reagents, instruments and software.

Help employers find you! Check out all the jobs and post your resume.

Back to news